Por Dr Varun Mehra
19.01.24
Hematología
Do I need to get my blood checked?
In his latest online article, renowned consultant haemato-oncologist Dr Varun Mehra explains when you should consider getting your blood checked by a specialist. He delves into the different possible conditions that can be detected in the blood, the signs of blood cancer and the different treatments available.
Por Dr Dionysis Papadatos-Pastos
19.10.23
Oncología Médica
An expert insight into targeted therapies for lung cancer
Targeted therapies, which are drugs designed to find and attack certain cancer cells, may be recommended instead or in combination with other cancer treatments for some types of lung cancer. Here, renowned consultant medical oncologist Dr Dionysis Papadatos-Pastos, provides an expert insight into how targeted therapies are used for lung cancer.
Por Professor Andrew Wardley
23.01.23
Oncología Médica
Systemic anti-cancer therapy: An expert guide
Leading consultant medical oncologist Professor Andrew Wardley explains what systemic anti-cancer therapy entails and how it can be used in the treatment of breast cancer in this informative article.
Por Professor Andrew Wardley
23.12.22
Oncología Médica
Tomorrow’s medicines today: Clinical trials for breast cancer drugs
Highly respected consultant medical oncologist and breast cancer specialist Professor Andrew Wardley shares his expertise on clinical trials for breast cancer drugs and how they have benefitted outcomes for patients over the years in this informative article.
Por Dr Varun Mehra
03.03.22
Hematología
Bone marrow transplant: who might require it?
Read our latest article to find out what exactly a bone marrow transplant is and who might need one, as leading London-based consultant haematologist, Dr Varun Mehra, answers all the commonly asked questions in relation to bone marrow transplants.
Por Dr Jaimal Kothari
15.09.21
Hematología
Myeloma: The right treatment for you
The symptoms of myeloma, the terminal bone marrow condition, can be relieved. There are aspects involved in the process that need to be carefully considered before starting treatment. The type of myeloma you have, your age and fitness levels are just some of the key factors that need to be assessed by a patient's healthcare team. Esteemed consultant haematologist, Dr Jaimal Kothari, has put together a comprehensive, reassuring guide to myeloma treatment that illustrates how patient quality of life always comes first.
Por Dr Jaimal Kothari
20.05.21
Hematología
Chronic Lymphocytic Leukaemia - definition, causes, symptoms, diagnosis and treatment
Chronic lymphocytic leukaemia (CLL) is a very slow growing type of blood cancer which begins in the bone marrow. Dr Jaimal Kothari is here to explain all you need to know about this condition.
Por Professor Hendrik Tobias Arkenau
04.03.21
Oncología Radioterápica
TIL therapy promising new cancer treatment explained
TIL therapy is an exciting new experimental cancer treatment that could help extend the lives of many cancer patients who fail to respond to standard treatments. But what is TIL therapy, how does it work and which cancers can it treat? Professor Hendrik-Tobias Arkenau, a top medical oncologist and drug developer in London explains.
Por Professor Hendrik Tobias Arkenau
08.02.21
Inmunología
Before undergoing immunotherapy, it's important to consider some of the following factors mentioned in this article. Professor Hendrik-Tobias (Tobi) Arkenau is a highly established medical oncologist, we recently spoke with him about the types of immunotherapy, the side effects and the success rate. In this article, he answers some of your frequently asked questions related to this treatment.
Por Professor Hendrik Tobias Arkenau
26.01.21
Oncología Médica
What are clinical trials how could they benefit you?
Deciding whether to be part of a clinical trial? Clinical trials for new cancer drugs are widely considered to be beneficial to cancer patients by potentially improving their treatment outcomes. Professor Hendrik-Tobias Arkenau, leading medical oncologist and the founding medical director of The Sarah Cannon Research Institute, explains who has access to them and how you can get involved.
Artículos médicos más leídos
Artículos médicos destacados